Short Term Effect and Safety of Antidiuretic Hormone in the Patients with Nocturia

다국어 초록 (Multilingual Abstract)

Purpose: To investigate the short-term safety of antidiuretic hormone in elderly patients with nocturnal polyuria, focus on hyponatremia and others electrolytes disturbances and to assess short-term effects on nocturnal urine output and number of nocturnal voids.
Methods: Between June 2005 and August 2006, a total of 34 patients with nocturnal polyuria were orally administered 0.2 mg desmopressin tablet at bedtime for two weeks. Serum sodium, others electrolytes, urine sodium and urine osmolarity were assessed in the third days, one week and two weeks after treatment with desmopressin and compared adult group (<65 years of age) with elderly group (≥65 years of age). We assessed the effect of desmopressin using a frequency-volume charts and analysed.
Results: In total 34 patients (20 adult, 14 elderly) were analyzed. Desmopressin treatment did not significantly change serum and urine electrolytes include soduim concentration in elderly patients comparied with adult patients. Serum sodium concentration below normal range was recorded in 2 patients in elderly group, but no serious adverse events occurred and recovered without sequelae. The mean number of nocturnal voids decresed (54% reduction) and nocturnal urine output decreased (57% reduction) after using desmopressin.
Conclusions: Desmopressin was well tolerated and effective in elderly patients with nocturnal polyuria without clinically significant hyponatremia.

참고문헌 (Reference)

1 Sommer P, "Voiding patterns in men evaluated by a questionnaire survey" 65 : 155-160, 1990

2 Homma Y, "Urinary symptoms and urodynamics in a normal elderly population" 15 : 1994

3 Simonsen O, "The significance of age on symptoms and urodynamic-and cystoscopic findings in benign prostatic hypertrophy" 15 : 355-358, 1987

4 Weatherall M, "The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis" 23 : 302-305, 2004

5 Chute CG, "The prevalence of prostatism: a population-based survey of urinary symptoms" 150 : 85-89, 1993

6 Asplund R, "The nocturnal polyuria syndrome (NPS)" 26 : 1203-1209, 1995

7 Kim ET, "The etiology and classification of nocturia in adults" 42 : 1075-1079, 2001

8 Hunsballe JM, "Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria" 158 (158): 830-836, 1997

9 Chang YL, "Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria" 177 : 2227-2229, 2007

10 Miller M, "Nocturnal polyuria in older people: pathophysiology and clinical implications" 48 : 1321-1329, 2000

11 Miller M, "Nocturnal polyuria in older people: pathophysiology and clinical implications" 48 : 1321-1329, 2000

12 Asplund R, "Nocturia, nocturnal polyuria, and sleep quality in the elderly" 56 : 517-525, 2004

13 Barker JC, "Nocturia in the elderly" 28 : 99-104, 1988

14 Asplund R, "Nocturia in relation to sleep, health, and medical treatment in the elderly" 96 (96): 15-21, 2005

15 Weiss JP, "Nocturia in adults:etiology and classification" 17 : 467-472, 1998

16 Weiss JP, "Nocturia" 163 : 5-12, 2000

17 Imai K, "Nippon Hinyokika Gakkai Zasshi" 82 : 1790-1799, 1991

18 Chang SC, "Multifactorial nature of male nocturia" 67 : 541-544, 2006

19 Weiss JP, "Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices" 18 : 559-565, 1999

20 Mattiasson A, "Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men" 89 : 855-862, 2002

21 Mattiasson A, "Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men" 89 : 855-862, 2002

22 Rembratt A, "Desmopressin treatment in nocturia;an analysis of risk factors for hyponatremia" 25 : 105-109, 2006

23 Rembratt A, "Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output,sleep and voiding patterns" 91 : 642-646, 2003